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ABSTRACT
Background: Intracytoplasmic sperm injection (ICSI) involves mechanical transfer of a single sperm cell into ooplasm. A new
application has been recently found for ICSI, the production of transgenic animals. Since the birth of ‘‘Dolly’’, the first adult
somatic cloned mammal, viable offspring has been produced by nuclear transfer in many species including cattle.  The present
review briefly summarizes our experience with ICSI and somatic cell nuclear transfer mainly to produce transgenic embryos,
as well as for the generation of new micromanipulation technique.
Review: We have evaluated different factors that affect SCNT and transgenesis including the chemical activator, the transfection
event and the effect of recloning. Also, we included a brief description of the ICSI technique, which we used in five different
species, examining its potential to produce transgenic embryos. Finally different strategies to produce transgenic animals were
analyzed: ICSI- mediated gen transfer (ICSI-MGT), Injection of cumulus cell and ooplasmic vesicle incubated for 5 min with
the transgene or injection of the plasmid alone. All of them were very efficient in exogenous DNA expression at embryo stages
but resulted in mosaic embryos.  We demonstrated that “ICSI-MGT” assisted by chemical activation is the only treatment of
sperm mediated gen transfer capable to generated transgenic embryos in ovine.  Besides, after ICSI-MGT, it is possible to
obtain enhanced green fluorescent protein (EGFP)-expressing embryos in five diferent species: ovine, porcine, feline, bovine
and equine. Our studies also established for the first time that short term transgene co-incubation with somatic cells can
produce transgene-expressing mammalian SCNT embryos, and also that parthenogenic, eDNA- expressing embryos can be
obtained by injection of vesicles or eDNA alone. Moreover, eDNA-expressing embryos can be also obtained by cytoplasmic
injection of vesicles in IVF zygotes, simplifying the traditional IVF pronuclear injection technique. We tried a further
simplification of the technique in bovine oocytes and zygotes, by intracytoplasmically injecting them with eDNA-liposomes
complexes. Approximately 70% of the cleaved embryos and 50% of the blastocysts expressed EGFP, when egfp–liposome was
injected 16 h post-fertilization. Different approaches were assayed to reverse the mosaicism including a novel technique of
gamete cloning. Our first approach consisted of the production of transgenic IVF embryos by vesicle microinjection to
generate transgenic blastomeres to be used as donor cells for cloning. A high efficiency in mosaicism reversal and multiplication
of transgenic embryos was attaineded. Other technique assayed was the separation of transgenic blastomeres followed by the
aggregation of two-cell fused embryos or by the asynchronous younger blastomere successfully multiplied transgenic embryos,
and theoretically reduces mosaicism rates in future offspring [15]. This technology can also be used to multiply embryos from
animals with high genetic value. We demonstrated that a sperm and oocyte can be efficiently cloned. Green haploid androgenic
blastomeres produced with the injection of a single sperm by egfp ICSI-MGT could be used to fertilized oocytes resulting in
several homogeneous expressing embryos. This approach shows great potential because it allows for determination of the sex
of the sperm nucleus prior to fertilization. It is also possible to clone previously transfected oocytes followed by the reconstruction
of biparental bovine embryos to generate homogeneous transgene-expressing embryos. This review summarizes recent
experiments in micromanipulation and gene transfer in domestic animals. The objective is not to exhaustedly describe the
research done in this field but to present the promising methods recently developed or evaluated in our lab.
Conclusion: Significant advancements have been made in the course of the recent years in micromanipulation and transgenesis
techniques.  In our lab we have been evaluating ICSI and Nuclear transfer mainly to produce transgenic embryos. We used also
transgensis to apply or developed new micromanipulation technique in domestic animals linke sperm and oocyte cloning.
Keywords: Micromanipulation, transgenesis, ICSI, cloning, nuclear transfer.
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I. INTRODUCTION
II. CLONING BY NUCLEAR TRANSFER
Cloning by somatic cell nuclear transfer has raised
enormous interest; mainly it has made possible the
propagation of elite domestic animals and the enginering
of transgenic animals for agricultural and biomedical
purposes. Briefly, nuclear transfer (NT) involves the
enucleation of a recipient oocyte, followed by the transfer
of a donor cell to the perivitelline space in close apposition
of the recipient cytoplast, and their fusion. Development
is induced artificially by chemical or physical activation.
Production of cloned offspring by somatic cell nuclear
transfer has been successfully attained in sheep [5,50,53],
goats [1] and cows [8,17,50].
There are several factors that influence the
results of NT including the methods of enucleation [26],
fusion, activation and donor-recipient cell cycle synchrony.
High efficiencies in enucleation of recipient oocytes have
been achieved using DNA specific vital dyes to visualize
chromatin [51,41]. Fusion of the donor cell with the
recipient oocyte depends on the accuracy of cell alignment
in the pulse field, contact of the donor cell with the
recipient oocyte and size of the donor cells [9]. Nucleus
can also be injected [6]. Activation of NT reconstructed
embryos has been refined and rates of development into
blastocysts are equivalent to in vitro fertilized oocytes
[21].
Successful development of NT embryos has been
accomplished using mature oocytes [52], zygote [24] and
cleavage-stage embryos [44] as recipient cytoplast.
However, this is dependent on the source of the donor
nucleus. Compatibility of the cell cycle between the
recipient cytoplasts and the donor cell is one of the
important factors that influence development of NT
embryos. Appropriate synchronization is necessary to
preserve the ploidy of the reconstituted embryo.
A problem with existing nuclear transfer systems
is that the survival of cloned embryos and fetuses is low.
One possible explanation is that the donor nucleus may
not be competent to support normal development. Somatic
cells have been programmed to differentiate into a parti-
cular cell; its nucleus is programmed to transcribe a
specific set of RNAs that are translated into a set of
proteins that results in the cell having all the characteristics
of its type. After nuclear transfer the nuclei condense,
and many proteins that bind to chromatin and regulate
transcription must be released. Other proteins may bind
at the time of activation to induce decondensation.
Reconstructed embryos can also present errors in genomic
imprinting. The modification or disruption of genomic
imprinting in early development may cause genetic
diseases. Embryo imprinting was evaluated by several
authors and may represent a problem for embryo or fetal
survival during reconstruction [14,33].
A new compound Dehydroleucodine (DhL) was
evaluated as a chemical activator to produce SCNT
reconstructed embryos [46]. Results showed that DhL
induces pronuclear formation dynamics more similar to
IVF than 6-dimethylaminopurine (6-DMAP). Blastocyst
development was higher after activation with this new
compound combined with Citochalasyn B. Moreover, all
DhL treatments induced polyploidy rates lower than
Ionomycin followed by 6-DMAP, but cloned blastocyst
rates statistically similar [6].
One of the main applications of SCNT is the
cloning of animals of genetic value. We assessed a new
alternative cloning technique, previously described in the
bovine [34], which consists of aggregating zone free
genetically identical cloned embryos as a strategy to
improve in vitro and in vivo embryo development in the
equine. Embryo aggregation improved the quality of in
vitro equine cloned embryos at day 7, and pregnancy
rates were higher. The sizes of vesicles and embryos in
vivo were normal for all groups, and in vitro development
of aggregated embryos beyond day 7 resulted in the
highest embryo viability. Cloning equines by means of
aggregation of two or three embryos does not imply ex-
tra oocytes, and it is a good strategy to improve in vitro
embryo development without alterations in in vivo
progress. The first living cloned foal obtained by this
method was born from two aggregated embryos On
August 4, 2010 [11].
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III. CLONING BY NUCLEAR TRANSFER USING A
TRANSFECTED CELL LINE
After nuclear transfer was developed, micro-
injection tended to be replaced by nuclear transfer using
genetically modified somatic donor cells [39,8]. A cow
capable of expressing human growth hormone (hGH)
was delivered in South America in September of 2002.
The hGH production in milk from this animal was
evaluated and results were published by Salamone et al.
[38] in 2006. It was demonstrated that hGH can be
produced at a large scale in the milk of transgenic cows.
Only about 15 animals would be necessary to meet the
worldwide requirements of this protein for the treatment
of dwarfism in GH deficient children [38]. However,
nuclear transfer as was described previously using
genetically modified somatic donor cells presents a low
overall efficiency, explained partly by epigenetic
reprogramming failure [36].
Although, cloning is one of the most powerful
techniques available to generate transgenic animals,
several additional problems appear during clone
production. For example, different transfection events of
the same somatic cell line can affect embryo and/or fetal
survival. In one experiment performed for a
Biotechnology company, a fetal cell line was established
from a 75-day-old Jersey female fetus, which was used
as control and was also transfected 3 times with the same
protocol. They were named Transfection 1, 2, and 3.
Genetically modified cells were produced and isolated
after selection with geneticin for 10–15 days following
liposome transfection with a DNA construct containing
a selectable neomycin resistance gene.
Results of embryo and fetal development are
presented in table 1. One birth was obtained from the
control. Four and 7 births were obtained from
Transfections 1 and 3, respectively. Although Transfection
Treatment n Blastocyst (%) Implanted Recipients Preg. 30d (%) Birth
Control 197 122 (62) 33 (18) 4 1
Transfection 1 130 106 (82) 28 (22) 5 4
Transfection 2 137 96 (70) 34 (24) 0 0
Transfection 3 470 282 (60) 71 (15) 12 7
Table 1. Effect off different transfection events on same line in embryo and fetal survival.
2 had good in vitro development, this treatment did
not produce any pregnancies. This fact demonstrated
that the transfection event provides an additional
source of variability in obtaining live transgenic
animals. Our results pointed out the necessity to
monitor fetal survival by ultrasonography in order to
detect any deficiencies in development introduced
by transfection as soon as possible.
In a large scale cloning program destined to obtain
transgenic animals, it is very important to produce well-
characterized transgene integration and gene expression.
However, after non-homologous transfections a wide
variety of transgene copy numbers are introduced in
different chromosome locations. Recloning a selected
first-generation of transgenic calves offers the opportunity
to increase the homogeneity among transgenic animals.
Calf recloning was performed in an experiment (n=
1739 cloning procedure) in which the survival rate
was evaluated after a second round of cloning from
transgenic umbilical cord and ear calf fibroblast cell
cultures. Seven births were obtained from the origi-
nal fetal cell line, one birth was obtained from recloned
umbilical cord cells and two calves from recloned
ear fibroblasts.  Development to blastocysts was
different between transfected fetal fibroblasts and
both recloned treatment groups. Differences were
observed in pregnancy rates between blastocysts
generated by the different sources of donor cells.
Although it results in lower blastocyst production,
our results suggest that recloning provides an additional
method to obtain transgenic animals, where fibroblasts
from umbilical cord tissue could give better results for
recloning than those obtained from young calf ear cells.
IV. INTRACYTOPLASMIC SPERM INJECTION (ICSI)
ICSI has been used in humans and mice [28,18].
In these species, sperm cell injection causes oocyte
activation [27]. However, after ICSI most domestic
Percentages within columns with different superscripts are different (P < 0.05)
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animals do not develop appropriately [23,22].
Chemical activation protocols for ICSI frequently use
ionomycin, a calcium ionophore, followed by 3 h of
incubation previous to 6-DMAP treatment [35].
Recently, we produced a high rate of ICSI blastocysts
in a domestic cat without chemical assisted activation,
simplifying the procedure, and allowing for its
application in the wild cat [25]. Most groups perform
ICSI using a piezo-drill, but we recently obtained
good blastocyst rates using chemical activation
protocols, producing a live lamb Fig. 2 [31]. In
equines this technique has great potential, because
although oocytes can be recovered in vivo via
ultrasound guided transvaginal aspiration, they are
impossible to fertilize by regular in vitro protocols.
ICSI appears to bypass this problem and we recently
generated good blastocyst rates in the equine.
V. ICSI MEDIATED GENE TRANSFER
Several authors published techniques
alternative to somatic cell nuclear transfer and
pronuclear microinjection to obtain transgenic
embryos and offspring including: Laparoscopic
Insemination (LI) [19], In Vitro Fertilization (IVF) [20]
and ICSI [32]. By LI and IVF, the possibility of
generating transgenic animals is simple. However the
use of these techniques has been in substantial deba-
te [20,4]. On the other hand, ICSI is an efficient
technique to produce offspring in the murine [32].
One of the limitations of ICSI-mediated gene
transfer is that it results in a high frequency of mosaic
expression of the transgene. A possible explanation for
this is that the transgene is not integrated in the embryo
genome before the first cell divisions [40,32,43,16].
Moreover, the transgene could remain extra-chromosomal
and be lost during successive mitotic divisions, as was
already shown in two previous reports [7].
In one experiment, we used “ICSI-MGT”
assisted by chemical activation in five species, ovine,
porcine, feline, bovine and equine, demonstrating that it
is possible to obtain enhanced green fluorescent protein
(EGFP)-expressing embryos in all of them. The
spermatozoa of the five species were coincubated with
pCX-EGFP plasmid and injected into the MII oocyte.
The chemical activation protocol was ionomycin followed
3 hours later by 3 hours of treatment with 6-DMAP. We
detected high proportions of the fluorescent EGFP
embryos in all five species (23 to 60%) at day four and
produced green blastocysts in bovine, ovine and cat [30].
In cattle, ICSI- mediated gene transfer was not
evaluated until a report by Pereyra et al. [30] in 2008.
The main reason for this is the poor outcome after
conventional ICSI in this species. In another study we
looked at the best conditions for intracytoplasmic ICSI-
MGT in cattle. Various aspects of fertilization and
embryonic development were assessed after five
activation treatments. Spermatozoa were co-incubated
with pCX-EGFP plasmid and injected into metaphase II
oocytes, which were then treated with ionomycin (Io)
before further activation with the following agents: 6-
DMAP (Io-DMAP), additional Io plus 6-DMAP (2Io-
DMAP), Io alone (2Io), ethanol (Io-EtOH), or strontium
chloride (Io-SrCl2). Fertilization rates at 16 h after ICSI,
presence of a condensed spermatozoon head on Day 4,
and blastocyst and EGFP expression rates on Day 7 were
evaluated. Fertilization rates did not differ significantly
among treatments. All (100%) of EGFP-positive embryos
resulted from ICSI fertilization, whereas at least 60% of
EGFP-negative embryos had a condensed sperm head.
Blastocyst rates after 2Io-DMAP were not significantly
different from Io-DMAP or Io-EtOH, but they were
higher than 2Io or Io-SrCl2 treatments (25.9, 18.7, 14.7,
9.4, and 10.9% respectively). In bovine, ICSI-MGT
proved to be a powerful technique because over 80% of
the blastocysts expressed EGFP protein [2]. We evaluated
LI, IVF and ICSI to produce egfp-expressing ovine
embryos, using spermatozoa previously exposed to pCX-
EGFP plasmid. High cleavage and morulae/blastocysts
rates were obtained with LI and IVF, but no egfp-
expressing embryos resulted. In contrast, 91.6% egfp-
expressing morulae and blastocysts were generated by
ICSI [29].
VI. GENE TRANSFER BY NUCLEAR MICROINJECTION
The first method reported to produce
transgenic animals was the microinjection of foreign
DNA into the male pronuclei of zygotes [12]. Trans-
genesis by microinjection is still used mainly for
research purposes in mice. This procedure has proven
to be efficient in species such as rabbits, sheep and
pigs [13], but it is quite dependent on proper male
pronuclei visualization and in some species, like the
bovine, the efficiency is very low [10].
VII. GENE TRANSFER BY CYTOPLASMIC
MICROINJECTION
Based in our results with ICSI, we tested if
the sperm cell was a special cell to transfer the
transgene, or if other cell types could also act as
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vectors. Surprisingly, when we injected cumulus cells
or oolemma vesicles previously incubated with
eDNA, and naked eDNA into the cytoplasm of MII
oocytes we observed expression of eDNA [29]. Using
confocal microscopy interaction, an interaction of
FITC- labeled eDNA with cumulus cells and vesicles
was demonstrated. In contrast, oocytes injected with
DNA alone did not show signs of transgene
accumulation, and their eDNA expression rates were
lower. In a further experiment, we evaluated if
transgene-expressing embryos could be produced by
means of vesicle injection followed by IVF.
Preliminary FISH analysis indicated detectable
integration events in 1/5 of SCNT blastocysts treated.
Our studies demonstrate for the first time that short
term transgene co-incubation with somatic cells can
produce transgene-expressing mammalian SCNT
embryos, and also that parthenogenic, eDNA-
expressing embryos can be obtained by injection of
vesicles or eDNA alone. Moreover, eDNA-expressing
embryos can be also obtained by cytoplasmic
injection of vesicles in IVF zygotes, simplifying the
traditional IVF pronuclear injection technique.
In other experiments different approaches were
studied to improve transgenesis efficiency and to avoid
mosaic expression patterns of transgene-expressing
embryos. Circular and linear plasmid structures and cell
cycle inhibitors (6-DMAP, and DhL) were tested to this
aim [3]. Egfp expression was higher for linear than cir-
cular pCX-EGFP, and green blastocyst rates were higher
for the groups inoculated with linear transgene incubated
with vesicles than for free linear plasmid alone. FISH
analysis showed integration evidence in green embryos.
The cell cycle inhibitor 6-DMAP increased phosphorylated
histone H2AX foci area, which mark DNA double
stranded breaks and reduced mosaic expression.
We tried a further simplification of the techniqe
in bovine oocytes and zygotes, by intracytoplasmically
injecting them with eDNA-liposomes complexes.
Approximately 70% of the cleaved embryos and 50% of
the blastocysts expressed EGFP, when egfp–liposome
was injected 16 h post-fertilization [48].
The percentage of integration of all these
methods remains to be confirmed.
VIII. DIFFERENT APPROACHES FOR EMBRYO
MULTIPLICATION AND MOSAICISM REVERSION
Our first approach consisted of the production
of transgenic IVF embryos by vesicle microinjection to
generate transgenic blastomeres to be used as donor
cells for cloning. A high efficiency in mosaicism
reversal and multiplication of transgenic embryos was
attaineded [3].
The separation of transgenic blastomeres
followed by the aggregation of two-cell fused embryos
or by the asynchronous younger blastomere successfully
multiplied transgenic embryos, and theoretically reduces
mosaicism rates in future offspring [15]. This technology
can also be used to multiply embryos from animals with
high genetic value.
Another technique that we assessed was
reducing mosaicism through gamete cloning. We
demonstrated that a sperm and oocyte can be efficiently
cloned [47,45,49]. Green haploid androgenic blastomeres
produced with the injection of a single sperm by egfp
ICSI-MGT could be used to fertilized oocytes resulting
in several homogeneous expressing embryos. This
approach shows great potential because it allows for
determination of the sex of the sperm nucleus prior to
fertilization. It is also possible to clone previously
transfected oocytes [49] followed by the reconstruction
of biparental bovine embryos to generate homogeneous
transgene-expressing embryos. This opens the possibility
for sperm or oocyte genome cloning by multiplying the
gamete in a haploid line. This would have the potential to
generate an unlimited number of biparental embryos by
combining these haploid cells with haploid hemizygotes
of the opposite sex.
The applications of these technologies are subject
to our capacity for imagination and innovation. Animals
that we have generated with some of these
methodologies (Figure 1, 2 and 3) have formed a kind of
postcard into the future that demonstrates the possibility
to use these technologies in our countries.
IX. CONCLUSIONS
Significant advancements have been made in
the course of the recent years in micromanipulation
and transgenesis techniques.  In our lab we have been
evaluating ICSI and Nuclear transfer mainly to produce
transgenic embryos. We used also transgenesis
developed to mark with flurorecence protein expression
and develop new micromanipulation technique in domestic
animals like gamete cloning. All these approach has
enormous potential for use in livestock production. One
of the main applications is introducing genes to modify
the genome for biomedicine or agriculture.
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Figure 1. BS Ñandubay Bicentenario cloned horse produce in 2010.
Figure 2. Pampa dynasty: clones produced from a Growth Hormone
transfected cell line in 2002.
Figure 3. Esperanza lamb generated by ICSI produced in 2008.
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